Last update 22 May 2025

Omigapil

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
CGP 3466, CGP 3466 maleate, CGP 3466B
+ [7]
Target
Action
inhibitors
Mechanism
GAPDH inhibitors(Glyceraldehyde-3-phosphate dehydrogenase liver inhibitors)
Active Indication-
Active Organization-
Drug Highest PhasePendingPhase 2
First Approval Date-
RegulationOrphan Drug (United States), Orphan Drug (European Union)
Login to view timeline

Structure/Sequence

Molecular FormulaC19H17NO
InChIKeyQLMMOGWZCFQAPU-UHFFFAOYSA-N
CAS Registry181296-84-4

External Link

KEGGWikiATCDrug Bank
-Omigapil-

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Amyotrophic Lateral SclerosisPhase 2
Belgium
01 Sep 2003
Amyotrophic Lateral SclerosisPhase 2
Canada
01 Sep 2003
Amyotrophic Lateral SclerosisPhase 2
France
01 Sep 2003
Amyotrophic Lateral SclerosisPhase 2
Germany
01 Sep 2003
Amyotrophic Lateral SclerosisPhase 2
Italy
01 Sep 2003
Amyotrophic Lateral SclerosisPhase 2
Netherlands
01 Sep 2003
Amyotrophic Lateral SclerosisPhase 2
Switzerland
01 Sep 2003
Amyotrophic Lateral SclerosisPhase 2
United Kingdom
01 Sep 2003
Parkinson DiseasePhase 2
United States
01 Jan 2002
Parkinson DiseasePhase 2
Brazil
01 Jan 2002
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1
20
(Cohort 1 0.02 mg/kg/Day)
srvrhhaqyd(moxvrcvxnw) = euxvdoustk stwxyyucui (ruqdyfogur, 32.4)
-
20 Sep 2019
(Cohort 2 0.08 mg/kg/Day)
srvrhhaqyd(moxvrcvxnw) = jkjpaycpcm stwxyyucui (ruqdyfogur, 24.9)
Pubmed
ManualManual
Phase 2/3
591
(1.0, 2.5, 7.5, or 15 mg/day)
kocawegemv(hbzkoxbyna) = stledlpfwd jbyqxzwtwb (kagzswypab )
Not Met
Negative
21 Aug 2007
placebo
-
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free